Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2025-12-25 @ 4:31 AM
NCT ID:
NCT00266318
Eligibility Criteria:
Inclusion Criteria:
* Must have documented failure to respond to past treatment with a Pegylated IFN + RBV. Failure to respond to past treatment is defined as positive HCV RNA at 12 weeks and less than a 2 log drop from baseline; OR positive HCV RNA and greater than 2 log drop from baseline at week 12 and must have received 24 weeks of therapy and still have a positive HCV RNA
* Must have tolerated previous hepatitis C therapy
* Must be off hepatitis C therapy for 3 months prior to study participation
* Must have had a liver biopsy within the past 5 years
Exclusion Criteria:
* Decompensated liver disease
* Laboratory abnormalities as per protocol
* HIV+
* Autoimmune disease
* Unstable or deteriorating cardiovascular or cerebrovascular disease
* History of seizures in past 5 years
* Alcohol or drug abuse in past year
* Pregnant or lactating women
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00266318
Study Brief:
Protocol Section:
NCT00266318